APPLIED THERAPEUTICS INC's ticker is APLT and the CUSIP is 03828A101. A total of 38 filers reported holding APPLIED THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $127,914 | +82.6% | 51,371 | -6.1% | 0.00% | – |
Q2 2023 | $70,047 | +43954.7% | 54,724 | +27820.4% | 0.00% | – |
Q1 2023 | $159 | -95.3% | 196 | -95.6% | 0.00% | – |
Q4 2022 | $3,406 | -81.1% | 4,480 | -77.7% | 0.00% | – |
Q3 2022 | $18,000 | -82.5% | 20,077 | -81.7% | 0.00% | – |
Q2 2022 | $103,000 | +139.5% | 109,596 | +436.6% | 0.00% | – |
Q1 2022 | $43,000 | -74.4% | 20,426 | +8.6% | 0.00% | – |
Q4 2021 | $168,000 | -30.6% | 18,809 | +28.9% | 0.00% | – |
Q3 2021 | $242,000 | -17.7% | 14,597 | +3.7% | 0.00% | – |
Q2 2021 | $294,000 | +11.4% | 14,081 | +0.1% | 0.00% | – |
Q1 2021 | $264,000 | +3.5% | 14,061 | +21.4% | 0.00% | – |
Q4 2020 | $255,000 | +99.2% | 11,578 | +88.5% | 0.00% | – |
Q3 2020 | $128,000 | -94.4% | 6,142 | -90.3% | 0.00% | -100.0% |
Q2 2020 | $2,278,000 | +1814.3% | 63,016 | +1636.0% | 0.00% | – |
Q1 2020 | $119,000 | -56.7% | 3,630 | -64.0% | 0.00% | – |
Q4 2019 | $275,000 | +4483.3% | 10,091 | +1859.4% | 0.00% | – |
Q3 2019 | $6,000 | – | 515 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 1,032,123 | $17,133,000 | 8.54% |
Orbimed Advisors | 2,257,387 | $37,473,000 | 0.41% |
EMERALD MUTUAL FUND ADVISERS TRUST | 621,317 | $10,314,000 | 0.36% |
EMERALD ADVISERS, LLC | 565,728 | $9,391,000 | 0.34% |
ACT CAPITAL MANAGEMENT, LLC | 37,500 | $623,000 | 0.32% |
Rock Springs Capital Management LP | 701,680 | $11,648,000 | 0.24% |
Artal Group S.A. | 400,000 | $6,640,000 | 0.15% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 639,557 | $10,617,000 | 0.13% |
Point72 Asset Management, L.P. | 1,015,271 | $16,853,000 | 0.07% |
Virtus ETF Advisers LLC | 8,790 | $146,000 | 0.06% |